Related Experiment Video
Updated: Dec 17, 2025
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration
Ali Mohammadi1,2, Behzad Mansoori1,3, Pascal H G Duijf4
1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:
Lung cancer is one of the most common cancers and its incidence is rising around the world. Various studies suggest that miR-330 acts as a tumor-suppressor microRNA (miRNA) in different types of cancers, but precisely how has remained unclear. In this study, we investigate miR-330 expression in lung cancer patient samples, as well as in vitro, by studying how normalization of miR-330 expression affects lung cancer cellular phenotypes such as viability, apoptosis, proliferation, and migration. We establish that low miR-330 expression predicts poor lung cancer prognosis. Stable restoration of reduced miR-330 expression in lung cancer cells reduces cell viability, increases the fraction of apoptotic cells, causes G2/M cell cycle arrest, and inhibits cell migration. These findings are substantiated by increased mRNA and protein expression of markers for apoptosis via the intrinsic pathway, such as caspase 9, and decreased mRNA and protein expression of markers for cell migration, such as vimentin, C-X-C chemokine receptor type 4, and matrix metalloproteinase 9. We showed that reduced miR-330 expression predicts poor lung cancer survival and that stable restoration of miR-330 expression in lung cancer cells has a broad range of tumor-suppressive effects. This indicates that miR-330 is a promising candidate for miRNA replacement therapy for lung cancer patients.
Insights
Low miR-330 expression indicates poor lung cancer prognosis. Restoring miR-330 in lung cancer cells suppresses tumor growth, viability, and migration, suggesting its potential for miRNA replacement therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer incidence is increasing globally, necessitating novel therapeutic targets.
- MicroRNA-330 (miR-330) is implicated as a tumor suppressor, but its role in lung cancer requires elucidation.
- Understanding miR-330's function is crucial for developing new lung cancer treatments.
Purpose of the Study:
- To investigate the expression and function of miR-330 in lung cancer.
- To determine the prognostic value of miR-330 in lung cancer patients.
- To evaluate the therapeutic potential of restoring miR-330 expression in lung cancer cells.
Main Methods:
- Analysis of miR-330 expression in lung cancer patient samples.
- In vitro studies assessing the impact of miR-330 restoration on lung cancer cell phenotypes (viability, apoptosis, proliferation, migration).
- Examination of apoptosis and migration marker expression at mRNA and protein levels.
Main Results:
- Low miR-330 expression correlates with poor lung cancer prognosis and survival.
- Restoration of miR-330 in lung cancer cells significantly reduced cell viability and migration.
- miR-330 re-expression increased apoptosis and induced G2/M cell cycle arrest, evidenced by altered apoptosis and migration markers.
Conclusions:
- miR-330 acts as a tumor suppressor in lung cancer.
- Reduced miR-330 expression is a predictive marker for poor lung cancer outcomes.
- miR-330 holds promise as a potential therapeutic agent for miRNA replacement therapy in lung cancer.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
02:23Abnormal Proliferation
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...